المؤلفون: Radivojev S; Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria; Center for Medical Research, Medical University of Graz, 8010 Graz, Austria., Kargl L; Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria., Pinto JT; Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria., Swedrowska M; King's College London, Institute of Pharmaceutical Science, SE1 9NH London, UK., Malmlöf M; Inhalation Sciences AB, Huddinge, Sweden., Meindl C; Center for Medical Research, Medical University of Graz, 8010 Graz, Austria., Forbes B; King's College London, Institute of Pharmaceutical Science, SE1 9NH London, UK., Gerde P; Inhalation Sciences AB, Huddinge, Sweden; Institute of Environmental Medicine, Karolinska Institutet, S-171 77 Stockholm, Sweden., Paudel A; Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria; Institute of Process and Particle Engineering, Graz University of Technology, Inffeldgasse 13, 8010 Graz, Austria., Fröhlich E; Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria; Center for Medical Research, Medical University of Graz, 8010 Graz, Austria. Electronic address: eleonore.froehlich@medunigraz.at.

المصدر: International journal of pharmaceutics [Int J Pharm] 2024 Aug 15; Vol. 661, pp. 124455. Date of Electronic Publication: 2024 Jul 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Mucus*/metabolism , Permeability* , Budesonide*/pharmacokinetics , Budesonide*/administration & dosage , Budesonide*/chemistry , Formoterol Fumarate*/administration & dosage , Formoterol Fumarate*/pharmacokinetics , Albuterol*/administration & dosage , Albuterol*/pharmacokinetics , Albuterol*/chemistry , Drug Liberation* , Tiotropium Bromide*/administration & dosage , Tiotropium Bromide*/pharmacokinetics , Tiotropium Bromide*/chemistry, Administration, Inhalation ; Swine ; Animals ; Humans ; Solubility ; Cell Line ; Bronchodilator Agents/administration & dosage ; Bronchodilator Agents/pharmacokinetics ; Bronchodilator Agents/chemistry ; Lung/metabolism ; Drug Compounding/methods

المؤلفون: Ikari J; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Chiba, Japan junikari@chiba-u.jp., Katsumata M; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Chiba, Japan., Urano A; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Chiba, Japan., Imamoto T; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Chiba, Japan., Suzuki Y; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Chiba, Japan., Nishiyama A; Department of Radiology, Tsudanuma Central General Hospital, Narashino, Chiba, Japan., Yokota H; Department of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Chiba, Japan., Ono K; Medical Imaging R&D Center, Healthcare Business Headquarters, Konica Minolta Inc, Chiyoda-ku, Tokyo, Japan., Okamoto K; Medical Imaging R&D Center, Healthcare Business Headquarters, Konica Minolta Inc, Chiyoda-ku, Tokyo, Japan., Abe E; Division of laboratory medicine, Chiba University Hospital, Chiba, Chiba, Japan., Kamata T; Division of laboratory medicine, Chiba University Hospital, Chiba, Chiba, Japan., Fujii S; Department of Radiology, Chiba University Hospital, Chiba, Chiba, Japan., Okumura K; Department of Radiology, Chiba University Hospital, Chiba, Chiba, Japan., Ota J; Department of Radiology, Chiba University Hospital, Chiba, Chiba, Japan., Suzuki E; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Chiba, Japan., Kawata N; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Chiba, Japan., Ozawa Y; Biostatistics Section, Clinical Research Center, Chiba University Hospital, Chiba, Chiba, Japan., Masuda Y; Department of Radiology, Chiba University Hospital, Chiba, Chiba, Japan., Matsushita K; Division of laboratory medicine, Chiba University Hospital, Chiba, Chiba, Japan., Sakao S; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Chiba, Japan.; Department of Respiratory Medicine, international university of health and welfare, Narita, Chiba, Japan., Uno T; Department of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Chiba, Japan., Tatsumi K; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Chiba, Japan., Suzuki T; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Chiba, Japan.

المصدر: BMJ open respiratory research [BMJ Open Respir Res] 2024 Aug 05; Vol. 11 (1). Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article; Clinical Trial Protocol; Comparative Study

بيانات الدورية: Publisher: BMJ Publishing Group Ltd & British Thoracic Society Country of Publication: England NLM ID: 101638061 Publication Model: Electronic Cited Medium: Internet ISSN: 2052-4439 (Electronic) Linking ISSN: 20524439 NLM ISO Abbreviation: BMJ Open Respir Res Subsets: MEDLINE

مواضيع طبية MeSH: Pulmonary Disease, Chronic Obstructive*/drug therapy , Pulmonary Disease, Chronic Obstructive*/diagnostic imaging , Pulmonary Disease, Chronic Obstructive*/physiopathology , Tiotropium Bromide*/administration & dosage , Tiotropium Bromide*/therapeutic use , Bronchodilator Agents*/therapeutic use , Bronchodilator Agents*/administration & dosage , Benzoxazines*/therapeutic use , Benzoxazines*/administration & dosage , Drug Combinations*, Humans ; Prospective Studies ; Aged ; Middle Aged ; Male ; Aged, 80 and over ; Female ; Adult ; Radiography, Thoracic ; Forced Expiratory Volume/drug effects ; Lung/diagnostic imaging ; Lung/physiopathology ; Lung/drug effects

المؤلفون: Choi KY; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do, Republic of Korea., Kim HI; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do, Republic of Korea., Rhee CK; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Yoo KH; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Konkuk University Hospital, School of Medicine, Konkuk University, Seoul, Republic of Korea., Park YB; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, Republic of Korea., Kim Y; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Konkuk University Hospital, School of Medicine, Konkuk University, Seoul, Republic of Korea., Lee SE; Respiratory, Medical Affairs, Boehringer-Ingelheim Korea, Seoul, Republic of Korea., Kim JA; Real-World Solutions, IQVIA Korea, Seoul, Republic of Korea., Hwang YI; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do, Republic of Korea.

المصدر: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2024 Jul 16; Vol. 19, pp. 1661-1671. Date of Electronic Publication: 2024 Jul 16 (Print Publication: 2024).

نوع المنشور: Journal Article; Comparative Study; Observational Study

بيانات الدورية: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2005 (Electronic) Linking ISSN: 11769106 NLM ISO Abbreviation: Int J Chron Obstruct Pulmon Dis Subsets: MEDLINE

مواضيع طبية MeSH: Pulmonary Disease, Chronic Obstructive*/drug therapy , Pulmonary Disease, Chronic Obstructive*/economics , Pulmonary Disease, Chronic Obstructive*/diagnosis , Adrenergic beta-2 Receptor Agonists*/economics , Adrenergic beta-2 Receptor Agonists*/administration & dosage , Drug Costs* , Databases, Factual* , Tiotropium Bromide*/administration & dosage , Tiotropium Bromide*/economics , Bronchodilator Agents*/economics , Bronchodilator Agents*/administration & dosage, Humans ; Republic of Korea/epidemiology ; Male ; Female ; Aged ; Middle Aged ; Treatment Outcome ; Time Factors ; Administration, Inhalation ; Muscarinic Antagonists/economics ; Muscarinic Antagonists/administration & dosage ; Muscarinic Antagonists/adverse effects ; Adrenal Cortex Hormones/administration & dosage ; Adrenal Cortex Hormones/economics ; Drug Combinations ; Cost-Benefit Analysis ; Retrospective Studies ; Cost Savings ; Health Resources/statistics & numerical data ; Health Resources/economics ; Lung/physiopathology ; Lung/drug effects

المؤلفون: Firlik KS; HealthPrize Technologies, Norwalk, CT, USA., Anupindi VR; IQVIA, Health Economics and Outcomes Research, Falls Church, VA, USA., Hayes V; HealthPrize Technologies, Norwalk, CT, USA., DeKoven M; IQVIA, Health Economics and Outcomes Research, Falls Church, VA, USA., Shaikh A; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA., Franchino-Elder J; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA.

المصدر: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2024 Sep; Vol. 24 (7), pp. 829-843. Date of Electronic Publication: 2024 Jan 04.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8379 (Electronic) Linking ISSN: 14737167 NLM ISO Abbreviation: Expert Rev Pharmacoecon Outcomes Res Subsets: MEDLINE

مواضيع طبية MeSH: Pulmonary Disease, Chronic Obstructive*/drug therapy , Pulmonary Disease, Chronic Obstructive*/economics , Tiotropium Bromide*/administration & dosage , Medication Adherence*/statistics & numerical data , Bronchodilator Agents*/administration & dosage , Bronchodilator Agents*/economics , Bronchodilator Agents*/therapeutic use, Humans ; Male ; Retrospective Studies ; Female ; Middle Aged ; Aged ; Cohort Studies ; Benzoxazines/administration & dosage ; Benzoxazines/economics ; Health Care Costs/statistics & numerical data ; Drug Combinations ; Administration, Inhalation ; Follow-Up Studies

المؤلفون: Perez-Bogerd S; Chest Department, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium., Van Muylem A; Chest Department, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium., Zengin S; Chest Department, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium., El Khloufi Y; Chest Department, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium., Maufroy E; Cardiopulmonary Exercise Laboratory, Faculty of Motorskill Science, Université Libre de Bruxelles, Brussels, Belgium., Faoro V; Cardiopulmonary Exercise Laboratory, Faculty of Motorskill Science, Université Libre de Bruxelles, Brussels, Belgium., Malinovschi A; Department of Medical Sciences: Clinical Physiology, Uppsala University, Uppsala, Sweden., Michils A; Chest Department, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.

المصدر: Journal of applied physiology (Bethesda, Md. : 1985) [J Appl Physiol (1985)] 2024 Jul 01; Vol. 137 (1), pp. 154-165. Date of Electronic Publication: 2024 May 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Physiological Society Country of Publication: United States NLM ID: 8502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-1601 (Electronic) Linking ISSN: 01617567 NLM ISO Abbreviation: J Appl Physiol (1985) Subsets: MEDLINE

مواضيع طبية MeSH: Pulmonary Disease, Chronic Obstructive*/drug therapy , Pulmonary Disease, Chronic Obstructive*/physiopathology , Pulmonary Disease, Chronic Obstructive*/metabolism , Muscarinic Antagonists*/pharmacology , Muscarinic Antagonists*/administration & dosage , Adrenergic beta-2 Receptor Agonists*/pharmacology , Lung*/metabolism , Lung*/drug effects , Lung*/physiopathology, Humans ; Male ; Female ; Aged ; Middle Aged ; Oxygen/metabolism ; Forced Expiratory Volume/drug effects ; Bronchodilator Agents/pharmacology ; Bronchodilator Agents/administration & dosage ; Tiotropium Bromide ; Drug Combinations ; Benzoxazines

المؤلفون: An TJ; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Kim JH; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Hur J; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Park CK; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Lim JU; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Kim S; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Rhee CK; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Yoon HK; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. cmcyhg@gmail.com.

المصدر: Journal of Korean medical science [J Korean Med Sci] 2023 Mar 27; Vol. 38 (12), pp. e91. Date of Electronic Publication: 2023 Mar 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Korean Academy of Medical Science Country of Publication: Korea (South) NLM ID: 8703518 Publication Model: Electronic Cited Medium: Internet ISSN: 1598-6357 (Electronic) Linking ISSN: 10118934 NLM ISO Abbreviation: J Korean Med Sci Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Histone Deacetylase 2*/metabolism , Tiotropium Bromide*/pharmacology, Animals ; Humans ; Mice ; Inflammation ; Lipopolysaccharides ; Mice, Inbred C57BL ; NF-kappa B/metabolism

المؤلفون: Dini N; Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Khoshbin AP; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Aliannejad R; Thoracic Research Center, Department of Internal Medicine, Division of Pulmonary and Critical Care, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran., Bakhshandeh H; Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran., Najafizadeh K; Shahid Beheshti University of Medical Sciences, Tehran, Iran., Mehdizadeh M; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Amini S; Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran. aminishahideh@gmail.com.

المصدر: Trials [Trials] 2024 Apr 06; Vol. 25 (1), pp. 243. Date of Electronic Publication: 2024 Apr 06.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

مواضيع طبية MeSH: Bronchiolitis Obliterans Syndrome* , Pulmonary Disease, Chronic Obstructive*/diagnosis , Pulmonary Disease, Chronic Obstructive*/drug therapy , Hematopoietic Stem Cell Transplantation*/adverse effects, Humans ; Tiotropium Bromide/adverse effects ; Cross-Over Studies ; Iran ; Bronchodilator Agents/adverse effects ; Double-Blind Method

المؤلفون: Matera MG; Unit of Pharmacology, Department of Experimental Medicine, School of Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy., Calzetta L; Unit of Respiratory Disease and Lung Function, Department of Medicine and Surgery, University of Parma, Parma, Italy., Rogliani P; Unit of Respiratory Medicine, Department Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy., Hanania N; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA., Cazzola M; Unit of Respiratory Medicine, Department Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy. mario.cazzola@uniroma2.it.

المصدر: Lung [Lung] 2024 Apr; Vol. 202 (2), pp. 119-125. Date of Electronic Publication: 2024 Feb 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: United States NLM ID: 7701875 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1750 (Electronic) Linking ISSN: 03412040 NLM ISO Abbreviation: Lung Subsets: MEDLINE

مواضيع طبية MeSH: Pulmonary Disease, Chronic Obstructive*/drug therapy , Pulmonary Disease, Chronic Obstructive*/epidemiology , Pulmonary Disease, Chronic Obstructive*/chemically induced , Cardiovascular Diseases*/chemically induced , Cardiovascular Diseases*/epidemiology, United States/epidemiology ; Humans ; Tiotropium Bromide/adverse effects ; Glycopyrrolate/adverse effects ; Retrospective Studies ; United States Food and Drug Administration ; Adrenergic beta-2 Receptor Agonists ; Drug Combinations ; Muscarinic Antagonists/therapeutic use ; Bronchodilator Agents ; Receptors, Muscarinic/therapeutic use ; Administration, Inhalation

المؤلفون: Bogart M; Customer Engagement, Value, Evidence and Outcomes (CEVEO) US Medical Affairs, GSK, Research Triangle Park, NC, USA., Leung GY; STATinMED Research, Dallas, TX, USA., Cyhaniuk A; STATinMED Research, Dallas, TX, USA., DiRocco K; US Medical Affairs, GSK, Collegeville, PA, USA.

المصدر: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2024 Feb 13; Vol. 19, pp. 439-450. Date of Electronic Publication: 2024 Feb 13 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2005 (Electronic) Linking ISSN: 11769106 NLM ISO Abbreviation: Int J Chron Obstruct Pulmon Dis Subsets: MEDLINE

مواضيع طبية MeSH: Pulmonary Disease, Chronic Obstructive*/diagnosis , Pulmonary Disease, Chronic Obstructive*/drug therapy , Quinuclidines*, Humans ; Aged ; United States ; Tiotropium Bromide/adverse effects ; Bronchodilator Agents/adverse effects ; Inpatients ; Retrospective Studies ; Aftercare ; Treatment Outcome ; Forced Expiratory Volume ; Administration, Inhalation ; Patient Discharge ; Medicare ; Benzyl Alcohols/adverse effects ; Chlorobenzenes/pharmacology ; Drug Combinations

المؤلفون: Wu F; State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; Guangzhou National Laboratory, Guangzhou, China., Dai C; State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Zhou Y; State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; Guangzhou National Laboratory, Guangzhou, China., Deng Z; State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Wang Z; State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Li X; State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Chen S; State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Guan W; State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Zhong N; State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; Guangzhou National Laboratory, Guangzhou, China., Ran P; State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; Guangzhou National Laboratory, Guangzhou, China. Electronic address: pxran@gzhmu.edu.cn.

المصدر: Respiratory medicine [Respir Med] 2024 Feb; Vol. 222, pp. 107527. Date of Electronic Publication: 2024 Jan 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3064 (Electronic) Linking ISSN: 09546111 NLM ISO Abbreviation: Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Bronchodilator Agents* , Pulmonary Disease, Chronic Obstructive*/complications , Pulmonary Disease, Chronic Obstructive*/drug therapy , Pulmonary Disease, Chronic Obstructive*/diagnosis, Humans ; Tiotropium Bromide/therapeutic use ; Forced Expiratory Volume ; Treatment Outcome